RESUMEN
Sorafenib is the oldest first line systemic treatment in patients with advanced hepatocellularcarcinoma (HCC) and has been used exclusively for nearly 10 years. The superiority ofadministering a combination of atezolizumab plus bevacizumab (AteBeva) compared tosorafenib as first line systemic treatment for unresectable HCC was recently proven duringthe IMbrave150 Phase III randomized trial. While clinicians can expect improved responsesand treatment outcomes due to the good results of the IMbrave 150 trial, they must alsoconsider that atezolizumab can cause various immune-related adverse events (IrAEs). Basedon the above suggestions, we herein present a case of HCC with lymph node metastasiswho achieved complete remission following treatment with AteBeva and developed an IrAE(adrenal insufficiency). Further study of real-life data regarding combination therapy withAteBeva is needed to manage patients with advanced HCC.
RESUMEN
Sorafenib is the oldest first line systemic treatment in patients with advanced hepatocellularcarcinoma (HCC) and has been used exclusively for nearly 10 years. The superiority ofadministering a combination of atezolizumab plus bevacizumab (AteBeva) compared tosorafenib as first line systemic treatment for unresectable HCC was recently proven duringthe IMbrave150 Phase III randomized trial. While clinicians can expect improved responsesand treatment outcomes due to the good results of the IMbrave 150 trial, they must alsoconsider that atezolizumab can cause various immune-related adverse events (IrAEs). Basedon the above suggestions, we herein present a case of HCC with lymph node metastasiswho achieved complete remission following treatment with AteBeva and developed an IrAE(adrenal insufficiency). Further study of real-life data regarding combination therapy withAteBeva is needed to manage patients with advanced HCC.
RESUMEN
Esophagogastroduodenoscopy (EGD) is considered a relatively safe procedure. However, the procedure and the materials used in EGD with conscious sedation can cause stress to the patient. Adverse events during EGD have been reported, represented by cardiopulmonary complications. To date, five cases have reported worldwide to be associated with gastrointestinal endoscopy. Stress cardiomyopathy (SCMP) is a reversible cardiomyopathy that typically occurs in postmenopausal women due to stress and may resolve within a few weeks. SCMP resembles acute myocardial infarction but differs in terms of treatment and prognosis. Here, we describe two cases of SCMP with shock during EGD with conscious sedation.
Asunto(s)
Femenino , Humanos , Cardiomiopatías , Sedación Consciente , Endoscopía del Sistema Digestivo , Endoscopía Gastrointestinal , Infarto del Miocardio , Pronóstico , Choque , Cardiomiopatía de TakotsuboRESUMEN
An angiosarcoma is a rare soft-tissue neoplasm that develops anywhere in the body, and most commonly presents cutaneously in elderly white males, involving the head and neck, particularly the scalp. The neoplasm occurs only very rarely in the gastrointestinal tract. A patient was initially admitted to our hospital for treatment of dyspnea and hemoptysis. Both lungs contained multiple nodules, and a computed tomography (CT)-guided lung biopsy was performed. Endogastroduodenoscopy used to evaluate the anemia revealed a duodenal polypoid tumor. Microscopic examination showed that the tumor was a primary angiosarcoma of the duodenum with metastasis to the lung. In addition, positron emission tomography/CT revealed metastasis to the femur and the pelvic bone. Thus, we report a case of primary duodenal angiosarcoma with metastases to the lung and bone.
Asunto(s)
Anciano , Humanos , Masculino , Anemia , Biopsia , Neoplasias Duodenales , Duodeno , Disnea , Electrones , Fémur , Tracto Gastrointestinal , Cabeza , Hemangiosarcoma , Hemoptisis , Pulmón , Cuello , Metástasis de la Neoplasia , Huesos Pélvicos , Cuero CabelludoRESUMEN
A 61-year-old male patient was admitted because of unexplained abdominal pain and anemia. His past medical history was unremarkable except for having taken herbal medicine to treat facial palsy two months ago. The result of health examination performed about a month ago showed increased serum aspartate and alanine aminotransferase level, and he was diagnosed with toxic hepatitis by herbal medicine. When the patient presented to the outpatient department three weeks ago, follow-up liver function test results showed improvement but he complained of abdominal pain. Despite extensive blood chemistry tests and computed tomography, the cause of pain could not be found. After much deliberation, serum lead level and herbal medicines analysis was performed based on the fact that he took herbal medicine two months ago, and he could finally be diagnosed with lead poisoning. Since the serum lead level was high enough to be indicated for lead chelating therapy, conservative management was given. When a patient with toxic hepatitis due to herbal medication presents with abdominal pain, the possibility of lead poisoning should always be taken into consideration.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Enfermedad Aguda , Alanina Transaminasa/análisis , Aspartato Aminotransferasas/análisis , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Hemoglobinas/análisis , Plomo/análisis , Intoxicación por Plomo , Hígado/enzimología , Pruebas de Función Hepática , Plantas Medicinales/químicaRESUMEN
Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder of the colon with a variable clinical course of exacerbation and remission. Extraintestinal manifestations of UC, including hematological disorders, such as the rare immune thrombocytopenic purpura (ITP), may be the presenting symptoms. We encountered the case of a 23-year-old man with UC who showed typical symptoms and endoscopic findings. Despite receiving steroid treatment, the patient developed severe thrombocytopenia. He was diagnosed with ITP, characterized by autoimmunity, a demonstrated low platelet count, normal bone marrow, positivity for autoantibody to platelet membrane antigen, and no splenomegaly. We initiated high dose intravenous immunoglobulin immediately for treatment of his steroid-refractory thrombocytopenia. The patient's hematochezia and platelet count improved following immunoglobulin treatment. After discharge, the patient's platelet count was maintained at a stable level and his condition was good. This case suggests that immunoglobulin therapy may be useful for treatment of ITP in UC.
Asunto(s)
Humanos , Adulto Joven , Autoinmunidad , Plaquetas , Médula Ósea , Colitis Ulcerosa , Colon , Hemorragia Gastrointestinal , Inmunización Pasiva , Inmunoglobulinas , Membranas , Recuento de Plaquetas , Púrpura Trombocitopénica Idiopática , Esplenomegalia , TrombocitopeniaRESUMEN
Hepatocellular carcinoma (HCC) usually metastasizes to the lung, breast, lymph nodes, gastrointestinal tract, bone, kidney, and/or adrenal gland. Metastasis of HCC to the hard palate and tonsils is a rare phenomenon. Thus, we report a case of HCC with metastasis to the hard palate and both tonsils in a 45-year-old man. The patient was admitted to our hospital with a complaint of oral bleeding. Physical examination revealed a bleeding tumor located in the hard palate and histological examination showed metastasis from HCC. The patient died 2 months later due to multiple organ failure, although bleeding was controlled by radiotherapy.